Balyasny Asset Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$726K Sell
370,310
-78,722
-18% -$185K ﹤0.01% 2211
2025
Q4
$1.22M Buy
449,032
+220,012
+96% +$722K ﹤0.01% 2098
2025
Q3
$969K Sell
229,020
-17,197
-7% -$75.6K ﹤0.01% 2125
2025
Q2
$1.23M Sell
246,217
-1,644
-0.7% -$7.14K ﹤0.01% 1967
2025
Q1
$1.09M Buy
247,861
+60,831
+33% +$286K ﹤0.01% 1952
2024
Q4
$870K Buy
+187,030
New +$1.03M ﹤0.01% 1993
2024
Q1
Sell
-85,527
Closed -$573K 2793
2023
Q4
$573K Buy
85,527
+27,115
+46% +$153K ﹤0.01% 1895
2023
Q3
$329K Sell
58,412
-368,376
-86% -$2.46M ﹤0.01% 1878
2023
Q2
$2.36M Buy
+426,788
New +$2.3M 0.01% 1330

Other funds holding GDRX

Balyasny Asset Management's GDRX Position: Q1 2026 in Review

Balyasny Asset Management reduced its GoodRx Holdings (GDRX) stake by 18% in Q1 2026, selling an estimated $185K and leaving 370,310 shares worth $726K. The position accounts for ﹤0.01% of the portfolio, ranked #2211.

Balyasny Asset Management first reported a position in GDRX in Q2 2023 and has held it in 9 quarters since. The position peaked at $2.36M in Q2 2023. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Balyasny Asset Management held 370,310 shares of GoodRx Holdings worth $726K as of Q1 2026.
  • Balyasny Asset Management sold 78,722 GoodRx Holdings shares in Q1 2026, an estimated $185K.
  • GoodRx Holdings made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2211 holding.
  • Balyasny Asset Management first reported a position in GoodRx Holdings in Q2 2023 and has held it in 9 quarters since.
  • Balyasny Asset Management's GoodRx Holdings position peaked at $2.36M in Q2 2023.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.